Filed: 8/14/2025ACC: 0000905148-25-002929
π What this filing means
VENBIO PARTNERS LLC filed this quarterly 13FβHR report disclosing 6 equity positions with a total reported market value of $114.76M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
6
Positions
$114.76M
Total AUM (reported)
20.72M
Total Shares
Allocation by class
COM$110.57M96.4%
COM NEW$4.19M3.6%
Portfolio Concentration
Top 3$104.81M91.3%
4β10$9.95M8.7%
Top 3 weight
91.3%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 20.72M
Sole
Full voting authority
20.72M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole6
Shared0
Other0
Dominant voting typeSole Β· 100.0% of voting shares
Institutional Holdings6
Rows:
PHARVARIS N V
SOLEShares4.29M
TypeSH
Market value$75.49M
65.78%
Sole
4.29M
Shared
0.00
None
0.00
HARMONY BIOSCIENCES HLDGS IN
SOLEShares489.19K
TypeSH
Market value$15.46M
13.47%
Sole
489.19K
Shared
0.00
None
0.00
ALUMIS INC
SOLEShares4.62M
TypeSH
Market value$13.86M
12.08%
Sole
4.62M
Shared
0.00
None
0.00
LYELL IMMUNOPHARMA INC
SOLEShares473.48K
TypeSH
Market value$4.19M
3.65%
Sole
473.48K
Shared
0.00
None
0.00
ALX ONCOLOGY HLDGS INC
SOLEShares9.70M
TypeSH
Market value$4.03M
3.51%
Sole
9.70M
Shared
0.00
None
0.00
ARTIVA BIOTHERAPEUTICS INC
SOLEShares1.15M
TypeSH
Market value$1.73M
1.51%
Sole
1.15M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting β Sole | Shared | None |
|---|---|---|---|---|---|---|---|
PHARVARIS N VSOLE | COM | 4.29M | SH | $75.49M 65.78% | 4.29M | 0.00 | 0.00 |
HARMONY BIOSCIENCES HLDGS INSOLE | COM | 489.19K | SH | $15.46M 13.47% | 489.19K | 0.00 | 0.00 |
ALUMIS INCSOLE | COM | 4.62M | SH | $13.86M 12.08% | 4.62M | 0.00 | 0.00 |
LYELL IMMUNOPHARMA INCSOLE | COM NEW | 473.48K | SH | $4.19M 3.65% | 473.48K | 0.00 | 0.00 |
ALX ONCOLOGY HLDGS INCSOLE | COM | 9.70M | SH | $4.03M 3.51% | 9.70M | 0.00 | 0.00 |
ARTIVA BIOTHERAPEUTICS INCSOLE | COM | 1.15M | SH | $1.73M 1.51% | 1.15M | 0.00 | 0.00 |